Drug Discovery and Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma and Biotech
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Resources
    • Video features
    • Podcast
    • Voices
    • Views
    • Webinars
  • Pharma 50
    • 2025 Pharma 50
    • 2024 Pharma 50
    • 2023 Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50
  • Advertise
  • SUBSCRIBE

Healthcare Repeal Attempt Likely If Republicans Win

By Drug Discovery Trends Editor | September 8, 2010

WASHINGTON (AP) – If you thought passing the health care overhaul was messy, wait until Republicans try to repeal it if they regain power this fall.

It could come down to who blinks first, with some Republicans raising the prospect of a government shutdown.

Even if Republicans succeed beyond any current predictions and capture both the Senate and the House, they wouldn’t have enough GOP votes to overcome President Barack Obama’s veto.

But Republicans could still fall back on the congressional power of the purse, denying the administration billions of dollars to carry out the most far-reaching social legislation since Medicare and Medicaid.

“The endgame is a fight over funding,” said Sen. Tom Coburn, R-Okla.

Faced with an opposition Congress “defunding” his health care plan, would Obama make a stand? Would he risk shutting down the Health and Human Services department, the IRS, or perhaps even the whole government?

“At that point, does he let everything else go?” asked former Rep. Tom Davis, a Virginia Republican elected in the GOP wave of 1994. “The game will be, does he shut the government down? Republicans can say, ‘We gave him the money to fund other programs.'”

Davis, a moderate who watched former Speaker Newt Gingrich lose a confrontation with then-President Bill Clinton over a government shutdown, cautioned both sides: “The question is, do you win that argument or not?”

White House officials wouldn’t comment.

The No. 2 House Democrat dismissed the talk of repeal as wishful thinking by Republicans. Majority Leader Steny Hoyer, D-Md., said he’s confident Democrats will stay in charge.

Even if Republicans win, “they can beat their chests and say they won’t fund the implementation of the law, but I think the law is the law, and if you can’t change it, then, frankly, you have a responsibility to carry it out,” Hoyer said.

But months after Obama signed the legislation, extensive efforts by his administration to tout its benefits for seniors and families, small employers and large corporations, have failed to rally public opinion.

Major components such as taxpayer-subsidized coverage for millions now uninsured, an IRS-enforced mandate that most Americans carry a policy, and guaranteed coverage for people in poor health are still more than three years away.

That’s a tantalizing opportunity for Republicans, and repealing “Obamacare” has become a campaign slogan in their drive to take the House. Some have proposed replacing the law with more modest alternatives.

“Repeal and replace” was the centerpiece this week on America Speaking Out, a website sponsored by the House GOP. They didn’t mince words.

“Obamacare will have dire consequences for our nation,” Rep. Steve King, R-Iowa, warned in a video on the site. “President Obama dismantled the finest medical system in the world and replaced it with a failed socialist model. The president nationalized your skin and everything inside it, and he enlarged the scope of the IRS by granting the agency the power to confiscate the assets of American who refuse to submit to the nanny state.”

Nothing of the sort, say health care law backers. The law’s requirement that most Americans carry insurance comes from a Republican proposal in the 1990s health care debate. Congress rejected a Medicare-like government option for all Americans that was the top priority for the political left. Most Americans will still have private insurance ten years from now.

Nonetheless, an advocacy arm of the Heritage Foundation, the prominent conservative think tank, is backing King’s effort to force a floor vote on repeal soon.

Hoyer believes that’s easier said than done. If Republicans win, “I think they would have second thoughts about repealing health care,” the Democratic leader predicted.

Republicans would face tricky political and policy challenges, he explained, listing a few:

– Would they allow insurance companies to again deny coverage to children with medical problems? The new law prohibits that.

– How would the GOP make up billions in lost federal revenue, since the Congressional Budget Office has ruled that the law reduces the deficit?

– Would Republicans bring back the coverage gap in the Medicare prescription drug benefit? The law gradually closes it.

“The pain that a family feels when their sick child is denied health care is real,” said Nadeam Elshami, a spokesman for Speaker Nancy Pelosi, D-Calif. “The threat by Republicans to take away patients’ rights and put insurance companies back in control just demonstrates the GOP’s commitment to the special interests.”

If Republicans win back the House, expect a House floor vote on repeal in short order, whether or not the GOP also controls the Senate. That’s the opening move, to send a message. What happens next is anybody’s guess.

Senate Republican Leader Mitch McConnell of Kentucky sought to lower expectations.

“I would like to repeal it and replace it,” McConnell told home state reporters recently. “What can we do? We can make narrow targeted efforts to go after the cost problems. Without the president, we can’t repeal it. But we can go after portions of it aggressively.”

One provision of the law is already on its way to being rescinded – a requirement that nearly 40 million businesses file tax forms for every vendor that sells them more than $600 in goods. Other targets include the fines for people who refuse to get coverage and a new long term care insurance program.

If Republicans get back in power, Coburn doesn’t think they can back off on repeal.

“If the Republicans are in control and they fund it – they’re history,” he warned.


Filed Under: Drug Discovery

 

Related Articles Read More >

Korean team reports all-in-one cancer nanomedicine in pre-clinical studies
Nektar’s Phase 2b atopic dermatitis win triggers 1,746% analyst target surge, but legal tussle with ex-partner Lilly could complicate path forward
Dupixent approved to treat bullous pemphigoid
EVEREST lead investigator on why Dupixent sets a new bar for treating coexisting CRSwNP and asthma
“ddd
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in the drug discovery and development industry.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Drug Discovery and Development
  • MassDevice
  • DeviceTalks
  • Medtech100 Index
  • Medical Design Sourcing
  • Medical Design & Outsourcing
  • Medical Tubing + Extrusion
  • Subscribe to our E-Newsletter
  • Contact Us
  • About Us
  • R&D World
  • Drug Delivery Business News
  • Pharmaceutical Processing World

Copyright © 2025 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Drug Discovery & Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma and Biotech
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Resources
    • Video features
    • Podcast
    • Voices
    • Views
    • Webinars
  • Pharma 50
    • 2025 Pharma 50
    • 2024 Pharma 50
    • 2023 Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50
  • Advertise
  • SUBSCRIBE